# AlphaResearch vs Floatz

AlphaResearch records 7,846 monthly visits with +39.8% month-over-month growth and Free Trial, Paid, Contact for Pricing pricing. Floatz records 253 monthly visits with -36.8% growth and Contact for Pricing pricing.

| Metric | [AlphaResearch](https://openaitools.app/tool/alpharesearch) | [Floatz](https://openaitools.app/tool/floatz-ai) |
| :--- | :--- | :--- |
| Website URL | https://alpharesearch.io | https://floatz.ai |
| Categories | AI Research Tool, AI For Finance, AI Search Engine, AI Investing | AI Healthcare, AI Research Tool, AI For Data Analytics, AI Report Generator |
| Pricing Model | Free Trial, Paid, Contact for Pricing | Contact for Pricing |
| Monthly Visits | 7,846 | 253 |
| MoM Growth Rate | +39.8% | -36.8% |
| Primary Market | United States | Switzerland |
| Direct Visits | 3,208 | 94 |
| Review Score | 4.2 | 3.8 |
| Saved Count | 4 | 17 |
| Supported Platforms | Website | Website |

## AlphaResearch

AlphaResearch addresses a familiar problem for investors: the signal you need is buried inside thousands of pages of filings and transcripts. The platform indexes millions of global documents — SEC and SEDAR filings, Company House records, international filings, press releases, earnings call transcripts and research reports — and lets you query them in plain language. Results can be highlighted, annotated and shared, so a research team can build on each other's findings instead of repeating the same manual reading.

Beyond raw search, AlphaResearch layers machine learning and NLP on top of the text. Users can track tone changes across a transcript, spot sentiment divergence between executives and analysts, monitor trending topics, and see which stocks retail investors are discussing. That qualitative layer sits alongside conventional quantitative data: fundamentals and analyst estimates, insider transactions, 13-F institutional ownership, ETF and mutual fund holdings, filings alerts and a stock screener.

The product is aimed at three audiences — institutional investors, corporate strategists and individual investors. Coverage is split by plan: the Basic tier focuses on the US market, while the Enterprise tier extends globally and adds Excel/Google Sheets add-ons, SLA terms and an account manager. Pricing starts at $49.99 per month billed quarterly for Basic, with a 7-day free trial and a limited free account that can be used indefinitely.

**Pricing & Plans:** Basic is $49.99/month billed quarterly with a 7-day free trial (credit card required) and covers the US market. Enterprise is custom-priced per seat with multi-seat discounts and adds global coverage, fundamentals, screeners and SLA support. A limited free account is available indefinitely.

- **Natural-language document search:** Query millions of SEC filings, transcripts, press releases and international documents in plain English and get the exact passage you need in seconds.
- **Sentiment and tone analytics:** Detect tone changes in earnings calls, spot sentiment divergence between executives and analysts, and follow trending topics across the market.
- **Fundamentals and estimates:** Institutional-grade fundamental data, market data, news and analyst estimates for financial modelling and stock research, including a global equity screener on the top tier.
- **Ownership and insider tracking:** Monitor 13-F institutional ownership, insider transactions, and ETF and mutual fund holdings alongside document alerts and a filings screener.
- **Research workspace and collaboration:** Highlight, annotate and save notes inside documents, then share findings with colleagues. Excel and Google Sheets add-ons are available on Enterprise.

**Strengths:** Single search layer across filings, transcripts, press releases and reports instead of scattered sources; NLP features such as tone-change and sentiment-divergence detection go beyond keyword search; Institutional-grade fundamentals and ownership data included, not just document text; Annotate, note and share research inside the platform, which suits team workflows

**Limitations:** Basic tier covers only the US market; global coverage requires custom Enterprise pricing; Full plan is priced quarterly rather than monthly, which raises the entry commitment; Best-in-class whole-team usage realistically requires the custom Enterprise tier

[Profile (Markdown)](https://openaitools.app/tool/alpharesearch.md)

## Floatz

Floatz positions itself as an AI research engine for life-science questions. Rather than relying on manual literature reviews, it indexes and summarises scientific publications so users can interrogate a therapeutic area, a target or a company's science and get a consolidated view in minutes rather than weeks.

The platform is aimed at two overlapping audiences: investors doing scientific due diligence on biotech and life-science assets, and research teams who need fast, cited groundwork on drug targets, pathways and emerging evidence. Results are presented as structured summaries with the underlying papers kept as traceable references.

Floatz does not publish self-serve pricing; the site directs buyers to request access, which is typical of enterprise/investor-grade research tools where seats and data volumes are negotiated. Because capabilities and data coverage evolve quickly, it is worth confirming the current scope of literature coverage directly with the vendor.

**Pricing & Plans:** Contact for pricing — Floatz does not list public plans on its website and directs interested users to get in touch.

- **Scientific literature search and analysis:** Search and analyse large bodies of scientific papers to answer specific research or therapeutic-area questions.
- **Structured summaries with sources:** Distils dense literature into readable, source-linked summaries so findings can be traced back to the original publications.
- **Target and pathway discovery support:** Helps surface high-potential drug targets and relevant biological pathways across large document sets.
- **Due-diligence workflows for investors:** Frames evidence around scientific risk so life-science investors can review a thesis before capital is committed.
- **Built for non-programmers:** A web interface aimed at analysts and researchers rather than bioinformaticians, so no coding or command-line work is required.

**Strengths:** Focuses on life-science evidence rather than generic text, so outputs are framed around targets, pathways and scientific risk; Saves the weeks normally spent on manual literature triage; Aims to keep summaries traceable to source publications, which matters for audit and investment memos; Browser-based, so analysts and investors can use it without a bioinformatics stack

**Limitations:** No public pricing or self-serve trial published on the site, so onboarding likely requires a sales conversation; Coverage and accuracy depend on the literature and data sources it indexes, which are not fully documented publicly; Best suited to life-science questions — it is not a general-purpose research assistant

[Profile (Markdown)](https://openaitools.app/tool/floatz-ai.md)

## Frequently Asked Questions

### How do AlphaResearch and Floatz compare in monthly traffic?

AlphaResearch has 7,846 monthly visits, while Floatz has 253. Traffic estimates describe audience size, not product quality.

### How do their growth rates compare?

AlphaResearch has a month-over-month growth rate of +39.8%; Floatz has -36.8%.

### How does pricing compare?

AlphaResearch: Free Trial, Paid, Contact for Pricing. Basic is $49.99/month billed quarterly with a 7-day free trial (credit card required) and covers the US market. Enterprise is custom-priced per seat with multi-seat discounts and adds global coverage, fundamentals, screeners and SLA support. A limited free account is available indefinitely. Floatz: Contact for Pricing. Contact for pricing — Floatz does not list public plans on its website and directs interested users to get in touch.

## Alternatives

| # | Tool Name | Monthly Visits | MoM Growth Rate | Pricing Model | Summary | Profile (Markdown) |
| :--- | :--- | :--- | :--- | :--- | :--- | :--- |
| 1 | [Semantic Scholar](https://openaitools.app/tool/semantic-scholar) | 8,198,672 | +5.8% | Free | A free, AI-powered academic search engine for 240M+ papers across every scientific field | [.md](https://openaitools.app/tool/semantic-scholar.md) |
| 2 | [Consensus](https://openaitools.app/tool/consensus) | 6,014,388 | -1.2% | Freemium | AI academic search engine for peer-reviewed science | [.md](https://openaitools.app/tool/consensus.md) |
| 3 | [SciSpace](https://openaitools.app/tool/scispace) | 4,464,111 | +8.6% | Freemium | AI research platform for reading, understanding and writing scientific papers | [.md](https://openaitools.app/tool/scispace.md) |
| 4 | [Elicit](https://openaitools.app/tool/elicit) | 1,751,507 | +3.1% | Freemium | AI research assistant for evidence-based literature review and synthesis | [.md](https://openaitools.app/tool/elicit.md) |
| 5 | [MacroMicro](https://openaitools.app/tool/macromicro) | 928,258 | +22.5% | Freemium, Paid | Global macro data and AI research platform for smarter economic decisions | [.md](https://openaitools.app/tool/macromicro.md) |
| 6 | [Scite](https://openaitools.app/tool/scite) | 841,974 | +1.1% | Free Trial, Contact for Pricing | AI answers grounded in 300M+ scholarly full texts | [.md](https://openaitools.app/tool/scite.md) |
| 7 | [Dr.Oracle](https://openaitools.app/tool/dr-oracle) | 723,847 | -1.2% | Free Trial | Guideline-directed medical answers with citations, built for clinicians | [.md](https://openaitools.app/tool/dr-oracle.md) |
| 8 | [Surf](https://openaitools.app/tool/surf) | 116,252 | -18.9% | Free, Pro, Max, API credits | Institution-grade crypto and equities intelligence, delivered through a chat-style AI analyst. | [.md](https://openaitools.app/tool/surf.md) |
| 9 | [Amsflow](https://openaitools.app/tool/amsflow) | 37,303 | +72.2% | Free Trial, Paid | Institutional-depth market research with an AI copilot that builds, backtests, and screens for you | [.md](https://openaitools.app/tool/amsflow.md) |
| 10 | [Unlearn.AI](https://openaitools.app/tool/unlearn-ai) | 17,107 | -32.5% | Contact for Pricing | AI-generated digital twins that make clinical trials smaller, faster, and more informative | [.md](https://openaitools.app/tool/unlearn-ai.md) |

---
Source: https://openaitools.app/compare/alpharesearch-vs-floatz-ai

More Markdown: [Categories](https://openaitools.app/categories.md) · [Traffic rankings](https://openaitools.app/rankings.md) · [llms.txt](https://openaitools.app/llms.txt)
